Earlier quoted context omitted.
I'm finding myself in disagreement with rule #6. Using a model effectively is about a lot more than just the domain knowledge. I'd value analysis from a mathematician/statistician more highly than from an infectious disease physician. There's the stuff that informs models, i.e. the observations, the experimentation etc. and then there's the science of modelling itself which isn't really in the same domain.
I agree with this - but I do think it should be clear that the model is from outside the mainstream. Not to dismiss it but to clarify its status. Check out the New Yorker piece I link to in the article - it's quite shocking the misinformation that's out there.
Likewise now with hydroxychloroquine--if you listen to the epidemiologists all you'd hear is how it's an UNPROVEN drug. What we need instead is coverage of sample sizes, p values, bayesian predictions of effectiveness (in the absence of controlled studies) and serious modeling of the number of ICU beds and ventilators required with and without various levels of treatment, from emergency care to prophylactic use.
The epidemiologists have their head in the sand and think we can just wait 6 months for a proper set of randomized trials. It's the less attached data modelers you need to turn to get predictions that are useful for effective policy choices.